Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-04-022126
Filing Date
2004-04-23
Accepted
2004-04-23 20:31:01
Documents
1
Period of Report
2004-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd40304.html 4  
1 FORM 4 rrd40304.xml 4 3495
  Complete submission text file 0001181431-04-022126.txt   5443
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114 2062817001
NEORX CORP (Issuer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 4156763830
BAY CITY CAPITAL FUND I L P (Reporting) CIK: 0001288444 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 04752439